{"id":1421,"date":"1999-06-01T12:01:00","date_gmt":"1999-06-01T10:01:00","guid":{"rendered":"https:\/\/der-arzneimittelbrief.com\/artikel\/1999\/unerwuenschte-wirkungen-von-zytostatika-2"},"modified":"2022-03-17T14:09:11","modified_gmt":"2022-03-17T13:09:11","slug":"unerwuenschte-wirkungen-von-zytostatika-2","status":"publish","type":"post","link":"https:\/\/der-arzneimittelbrief.com\/artikel\/1999\/unerwuenschte-wirkungen-von-zytostatika-2","title":{"rendered":"Unerw\u00fcnschte Wirkungen von Zytostatika"},"content":{"rendered":"<p>Die heute in der Tumortherapie eingesetzten zytostatisch wirksamen Medikamente entstammen unterschiedlichen Substanzgruppen. Neben der Einteilung nach Substanzklassen mit Untergruppen und Einzelsubstanzen (s. Tab. 1) werden Zytostatika auch eingeteilt nach ihrer Wirkung auf den Zellzyklus in phasenspezifische (wirken nur w\u00e4hrend bestimmter Phasen des Zellzyklus), zyklusspezifische (erfassen alle Phasen des Zellzyklus au\u00dfer der G0-Phase) und zyklusunspezifische (erfassen [&hellip;]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Die heute in der Tumortherapie eingesetzten zytostatisch wirksamen Medikamente entstammen unterschiedlichen Substanzgruppen. Neben der Einteilung nach Substanzklassen mit Untergruppen und Einzelsubstanzen (s. Tab. 1) werden Zytostatika auch eingeteilt nach ihrer Wirkung auf den Zellzyklus in phasenspezifische (wirken nur w\u00e4hrend bestimmter Phasen des Zellzyklus), zyklusspezifische (erfassen alle Phasen des Zellzyklus au\u00dfer der G0-Phase) und zyklusunspezifische (erfassen [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[189,2443,1964,3413,3049,1967,704,33,1965,701,705,30,188,27,457,700,1963,274,703,706,3412,392,393,270,39,35,707,710,1144,3415,1968,286,276,832,278,279,280,3414,3416,1961,1960,698,740,365,3411,1958,265,3410,697,262,264],"class_list":["post-1421","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-2-chlordesoxyadenosin","tag-6-mercaptopurin","tag-alkylanzien","tag-altretamin","tag-amsacrin","tag-anthrazykline","tag-bleomycin","tag-busulfan","tag-carboplatin","tag-carmustin","tag-chlorambucil","tag-cisplatin","tag-cladribin","tag-cyclophosphamid","tag-cytarabin","tag-dacarbazin","tag-dactinomycin","tag-docetaxel","tag-doxorubicin","tag-epirubicin","tag-estramustinphosphat","tag-etoposid","tag-fludarabin","tag-gemcitabin","tag-hydroxycarbamid","tag-hydroxyurea","tag-idarubicin","tag-ifosfamid","tag-irinotecan","tag-l-asparaginase","tag-lomustin","tag-melphalan","tag-methotrexat","tag-miltefosin","tag-mitomycin-c","tag-mitoxantron","tag-paclitaxel","tag-pentostatin","tag-plicamycin","tag-taxane","tag-teniposid","tag-thioguanin","tag-thiotepa","tag-topotecan","tag-vepesid","tag-vinca-alkaloide","tag-vincristin","tag-vindesin","tag-vinorelbin","tag-zytostatika","tag-zytostatische-therapie"],"_links":{"self":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/1421","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/comments?post=1421"}],"version-history":[{"count":0,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/1421\/revisions"}],"wp:attachment":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/media?parent=1421"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/categories?post=1421"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/tags?post=1421"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}